These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18668137)

  • 21. Incidence and trends of first basal cell carcinomas in France between 1980 and 2019: a regional population-based registry study.
    Hammas K; Nardin C; Boyer S; Michel C; Aubin F; Woronoff AS
    Br J Dermatol; 2024 Sep; 191(4):519-528. PubMed ID: 38748494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
    Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
    J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
    Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
    Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomic location and histopathologic subtype of basal cell carcinomas in adults younger than 40 or 90 and older: any difference?
    Betti R; Radaelli G; Mussino F; Menni S; Crosti C
    Dermatol Surg; 2009 Feb; 35(2):201-6. PubMed ID: 19215256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of basal cell carcinoma in Lithuania, 1996-2010.
    Jurciukonyte R; Vincerzevskiene I; Krilaviciute A; Bylaite M; Smailyte G
    Br J Dermatol; 2013 Nov; 169(5):1100-5. PubMed ID: 23795568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
    Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
    Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthropometric measures, medical history and risk of basal cell carcinoma in an Italian case-control study.
    Pelucchi C; Naldi L; Di Landro A; La Vecchia C;
    Dermatology; 2008; 216(3):271-6. PubMed ID: 18196938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors.
    Bastiaens MT; Hoefnagel JJ; Bruijn JA; Westendorp RG; Vermeer BJ; Bouwes Bavinck JN
    J Invest Dermatol; 1998 Jun; 110(6):880-4. PubMed ID: 9620293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence and multiplicity rates of keratinocyte cancers in Australia.
    Pandeya N; Olsen CM; Whiteman DC
    Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995.
    Plesko I; Severi G; Obsitníková A; Boyle P
    Neoplasma; 2000; 47(3):137-42. PubMed ID: 11043834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
    Youl PH; Janda M; Aitken JF; Del Mar CB; Whiteman DC; Baade PD
    Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Teenage BCC: to tan or not to tan?'.
    Douglas HE; Agarwal R; Lam DG
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1245-6. PubMed ID: 18541465
    [No Abstract]   [Full Text] [Related]  

  • 35. Trends in Basal cell carcinoma incidence rates: a 37-year Dutch observational study.
    Flohil SC; Seubring I; van Rossum MM; Coebergh JW; de Vries E; Nijsten T
    J Invest Dermatol; 2013 Apr; 133(4):913-8. PubMed ID: 23190883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of basal cell carcinoma in a tertiary hospital in Sarawak, Malaysia.
    Yap FB
    Int J Dermatol; 2010 Feb; 49(2):176-9. PubMed ID: 20465642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excising basal cell carcinoma in general practice.
    Bostock-Ling N
    Aust Fam Physician; 2006 Jul; 35(7):558-60. PubMed ID: 16820836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An increase in basal cell carcinoma among the young: an epidemiological study in a middle-south Italian population.
    Delfino S; Innocenzi D; Di Lorenzo G; Scalvenzi M; Montesarchio V; Feroce F; Baldi A; Persichetti P
    Anticancer Res; 2006; 26(6C):4979-83. PubMed ID: 17214374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.